Life insurers sit near highs on 5% yields while P&C softens. MET, PRU, CRBG, EQH, LNC, APO/Athene, RNR, NAIC private-credit rules, scenarios and options ideas.
Nicotine pouches hit 60% of US oral tobacco while FDA weighs a new approval rule. PM, MO, BTI, TPB, scenarios and Wick's take.
Regional-bank margins are inching up while deposit costs and commercial real estate cloud the outlook. KRE, PNC, USB, TFC, MTB, RF, CFG, FITB, KEY, ZION, WAL, FLG, scenarios and options ideas.
Water stocks lag as yields bite; Xylem reports Oct 27 and American Water gives 2027 guidance Oct 29. XYL, AWK, WTS, PNR, ECL, scenarios and Wick's take.
XLF lags SPY as private-credit landlords sink and toll roads thrive. JPM, MS, SCHW, BLK, BX, APO, OWL, ICE, CME, V, MA, Blue Owl redemptions, earnings calendar, scenarios and options ideas.
Symbotic's $22.5B backlog, Teradyne's cobots and Rockwell's factory controls versus the humanoid hype. ROK, TER, SYM, ZBRA, ISRG, scenarios and Wick's take.
Lilly's Foundayo and Novo's Wegovy pill trade dueling data while Novo resets guidance and cuts prices. LLY, NVO, AMGN, VKTX, HIMS, scenarios and Wick's take.
Aritzia jumped 20% on a 44% sales surge while Lululemon guides Q3 revenue down 10–11%. LULU, ATZ, ANF, GAP, VSXY, URBN, RL, TPR, LEVI, Shein/Temu, tariffs, scenarios and Wick's take.
Chip-equipment stocks fall 2–7% as China's CXMT memory push hits the sector days before ASML and TSMC report. ASML, AMAT, LRCX, KLAC, TER, ONTO, scenarios and Wick's take.
IonQ falls 9% on an all-stock deal for Elisity worth up to $1.3B and drags Rigetti, D-Wave and QUBT lower. Dilution, funding, the giants vs pure plays, scenarios and Wick's take.
Coca-Cola sits 3% from its high while PepsiCo trades near its 52-week low after a guidance cut and a wave of target cuts. KO, PEP, KDP, MNST, STZ, DEO, TAP, SAM, CELH, scenarios and Wick's take.
Nucor lifts its HRC spot price for a fifth straight week to $1,240/st as mill outages and Section 232 tariffs keep supply tight. NUE, STLD, CLF, MT, CMC, RS, SLX, scenarios and Wick's take.
